• Home
  • The company
      • Back
      • Profile
      • Strategy
      • Goals
      • Partnering
      • Certifications
  • Partners
      • Back
      • Diagnostic Green
      • Hameln Pharm
      • Abanta Pharma
      • Mastelli
  • Products
      • Back
      • Condrotide
      • Condrotide HA
  • Careers
  • Contact us

Condrotide

Condrotide

Indications

  • Painful joint diseases caused by degenerative
  • or post- traumatic conditions or by modification of a joint
  • This product helps to restore the rheological
  • and physiological conditions of the joints
  • It reduces pain
  • It protects the joints
  • It performs trophic action on the joint cartilage
  • improving cellular activity
  • The only alternative to Hyaluronic acid
  • Beneficial, safe, effective and innovative for intra-articular treatments
  • Trophic effect on the cartilage (Gennero et al. 2014)
  • Natural
  • 3 clinical trials
  • Publication of numerous clinical and experimental studies supporting the findings
  • High tolerability


Condrotide / Product Description

Product description:

  • 40 mg/2 ml polynucleotides (of fish origin)
  • 2 ml solution
  • Sterile, non-pyrogenic, pre-filled glass syringe for single use
  • International patent: EP 2358373



CONDROTIDE

Polynucleotides
Polynucleotides characteristics:

  • Extracted from fish: natural origin
  • Perform a regenerative effect
  • Have a proven effect on wound healing
  • For acute, chronic and surgical wounds
  • High safety and tolerability
  • Perform a trophic and metabolic action on fibroblasts
  • Thanks to its regenerative effect, PN effectively treat damaged, senescent and atrophic tissues both
  • in in vitro and in vivo models

 

 

MORE INFO:

Main Principles of Joints Anatomy, Physiology and Pathology

 

CLINICAL TRIALS:

2012 2013 Gennero et al Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures
2014 Giarratana Marelli A randomized double-blind clinical trial on the treatment of knee osteoarthritis
2014 Saggini et al - Viscosupplementation with hyaluronic acid or Polynucleotides rotator cuff
2016 Saggini et al - La condro-sincronizzazione nel danno articolare complesso

 

ATP Pharma P.C.

ATP Alpha Pharmacy, Ελληνική φαρμακευτική εταιρεία

ATP Pharma P.C.,

57, Akadimias Street, 106 79 Athens, Greece

Tel.: +30 216 0707646

E-mail: [email protected]

Web: atp-pharma.gr

Useful links

• Institute of Pharmaceutical Research and Technology (IPRT S.A.)
https://www.ifet.gr/

• National Drug Organization (NDO)
http://www.eof.gr/

• European Medicines Agency (EMA)
http://www.ema.europa.eu/ema/

Certificates - Certificates

© ATP Pharma 2023
Greek pharmaceutical company

Πάνω